Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
The Journal of Allergy and Clinical Immunology
|
November 27, 2015
Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
Emma Guttman-Yassky, Benjamin Ungar, Shinji Noda, et al.
Archives of Dermatological Research
|
March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI
Hee J Kim, Ester Del Duca, Ana B Pavel, et al.
Journal of the American Academy of Dermatology
|
January 13, 2021
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study
Hee J Kim, Giselle K Singer, Ester Del Duca, et al.
Angewandte Chemie (International Ed. in English)
|
April 3, 2024
PyrAtes: Modular Organic Salts with Large Stokes Shifts for Fluo-rescence Microscopy
Iakovos Saridakis, Margaux Riomet, Oliver J V Belleza, et al.
The Journal of Allergy and Clinical Immunology
|
May 20, 2020
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Benjamin Ungar, Ana B Pavel, Randall Li, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Chemical Science
|
March 12, 2025
Fluorescent PyrAte-(<i>S</i>)-citalopram conjugates enable imaging of the serotonin transporter in living tissue
Oliver J V Belleza, Iakovos Saridakis, Nadja K Singer, et al.
Journal of the American Academy of Dermatology
|
January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Emma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Hospital Pharmacy
|
November 4, 2024
Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers
Sarah K Singer, Kevin D Betthauser, Alexandra E Barber, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
The Journal of Allergy and Clinical Immunology
|
November 27, 2015
Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
Emma Guttman-Yassky, Benjamin Ungar, Shinji Noda, et al.
Archives of Dermatological Research
|
March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI
Hee J Kim, Ester Del Duca, Ana B Pavel, et al.
Journal of the American Academy of Dermatology
|
January 13, 2021
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study
Hee J Kim, Giselle K Singer, Ester Del Duca, et al.
Angewandte Chemie (International Ed. in English)
|
April 3, 2024
PyrAtes: Modular Organic Salts with Large Stokes Shifts for Fluo-rescence Microscopy
Iakovos Saridakis, Margaux Riomet, Oliver J V Belleza, et al.
The Journal of Allergy and Clinical Immunology
|
May 20, 2020
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Benjamin Ungar, Ana B Pavel, Randall Li, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Chemical Science
|
March 12, 2025
Fluorescent PyrAte-(<i>S</i>)-citalopram conjugates enable imaging of the serotonin transporter in living tissue
Oliver J V Belleza, Iakovos Saridakis, Nadja K Singer, et al.
Journal of the American Academy of Dermatology
|
January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Emma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Hospital Pharmacy
|
November 4, 2024
Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers
Sarah K Singer, Kevin D Betthauser, Alexandra E Barber, et al.
Page
of 14